Abstract
Glioblastoma multiforme (GBM) accounts for about 80% of all adult malignant gliomas. Despite aggressive surgery, chemotherapy and radiation therapy, GBM continues to be one of the most intractable brain tumors. The median and 5-year survivals are typically 9 to 10 months and <5%, respectively.1 For primary malignant brain tumors, the most powerful prognostic factors are histology, age and functional status.2 Although GBM rarely metastasizes to other sites and organs, the tumor cells infiltrate deeply into the surrounding brain and may even reach the contralateral hemisphere. External beam photon radiation therapy cannot ablate the infiltrating GBM cells because radiation doses high enough to kill those cells would cause unacceptable necrosis of normal brain tissues. Boron neutron capture therapy (BNCT) has the potential to address this inadequacy through a more selective Irradiation of GBM cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F.G. Davis, S. Freels, J. Grutsch, S. Barlas, and S. Brem, Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991, J. Neurosurg., 88:1–10, 1998.
W.J. Curran, CB Scott, J. Horton, J.S. Nelson, A.S. Weinstein, A.J. Fischbach, C.H. Chang, M. Rotman, S.O. Asbell, R.E. Krisch, and D.F. Nelson, Recursive partitioning analysis of prognostic factors in three radiation oncology group malignant glioma trials, J. Nat. Cancer Inst., 85:704–710, 1993.
H. Hatanaka, and Y. Nakagawa, Clinical results of long surviving brain tumor patients who underwent boron neutron capture therapy, Int. J. Radiat. Oncol. Biol. Phys., 28:1061–1066, 1994.
J.A. Coderre, T.M. Button, P.L. Micca, C. Fisher, M.M. Nawrocky, and H.B. Liu, Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex, Int. J. Radiat. Oncol. Biol. Phys., 30:643–652, 1994.
J.S. Nelson, Y. Tsukada, D. Schoenfeld, K. Fulling, J. Lamarche, and N. Peress, Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas, Cancer, 52:550–554, 1983.
R.G. Fairchild, D. Gabel, B.H. Laster, D. Greenberg, W. Kiszenick, and P. Micca, Microanalytical techniques for boron analysis using the 10B(n,α)7Li reaction, Med. Phys., 13:50–56, 1986.
W. Bauer, P. Micca, and B. White, A rapid method for the direct analysis of boron in whole blood by atomic emission spectroscopy, in: “Advances in Neutron Capture Therapy”, A.H. Soloway, R.F. Barth, and D.E. Carpenter, eds., Plenum Press, New York, pp. 403–407, 1993.
J.A. Coderre, A.D. Chanana, D.D. Joel, E.H. Elowitz, P.L. Micca, M.M. Nawrocky, M. Chadha, J.O. Gebbers, M. Shady, N.S. Peress, and D.N. Slatkin, Biodistribution of P-boronophenylalanine in patients with glioblastoma multiforme: Boron concentration correlates with tumor cellularity, Radiat. Res., 149:163–170, 1998.
M. Chadha, J. Capala, J.A. Coderre, E.H. Elowitz, J. Iwai, D.D. Joel, H.B. Liu, L. Wielopolski, and A.D. Chanana, Boron neutron capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory, Int. J. Radiat. Oncol. Biol. Phys., 40:829–834, 1998.
L. Wielopolski, J. Capala, M. Chadha, N. Pendzick, and A.D. Chanana, Considerations for patient positioning in static beams for BNCT, in: “Advances in Neutron Capture Therapy, Volume I, Medicine and Physics,” B. Larsson, J. Crawford, and R. Weinreich, eds., Elsevier, Amsterdam, pp. 357–360, 1997.
H.B. Liu, D.D. Greenberg, J. Capala, J.A. Coderre, and F.J. Wheeler, An improved neutron collimator for brain tumor irradiation in clinical boron neutron capture therapy, Med. Phys., 23:2051–2060, 1996.
J.D. Cox, J. Stetz, and T.F. Pajak, Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC), Int. J. Radiat. Oncol. Biol. Phys., 31:1341–1346, 1995.
P.J. Kelly, C. Daumas-Duport, B.W. Sheithauer, and D.B. Kispert, Stereotactic histologic correlations of computed tomography-and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms, Mayo Clin. Proc., 62:450–459, 1987.
G.M. Morris, J.A. Coderre, J.W. Hopewell, P.L. Micca, and L. Wielopolski, Boron neutron capture therapy: Re-irradiation response of the rat spinal cord, Radiother. Oncol., (in press).
G.M. Morris, J.A. Coderre, J.W. Hopewell, P.L. Micca, M.M. Nawrocky, H.B. Liu, and T. Bywaters, Response of the central nervous system to boron neutron capture irradiation: Evaluation using rat spinal cord model, Radiother. Oncol, 32:249–255, 1994.
J.A. Coderre, M.S. Makar, P.L. Micca, M.M. Nawrocky, H.B. Liu, D.D. Joel, D.N. Slatkin, and H.I. Amols, Derivations of relative biological effectiveness for the high-LET radiation produced during boron neutron capture irradiations of the 9L rat gliosarcoma in vitro and in vivo, Int. J. Radiat. Oncol. Biol. Phys., 27:1121–1129, 1993.
H. Fukuda, J. Hiratsuka, C. Honda, T. Kobayashi, K. Yoshino, H. Karashima, J. Takahashi, Y. Abe, K. Kanda, M. Ichihashi, and Y. Mishima, Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the skin, Radiat. Res., 138:435–42, 1994
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Diaz, A.Z. et al. (2001). Boron Neutron Capture Therapy for Glioblastoma Multiforme. In: Hawthorne, M.F., Shelly, K., Wiersema, R.J. (eds) Frontiers in Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1285-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1285-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5478-9
Online ISBN: 978-1-4615-1285-1
eBook Packages: Springer Book Archive